Wegovy and Zepbound are still hard to get. Knockoff versions from Noom, Ro, and others are filling in the gaps.

Not everybody loses the same amount of weight on medications such as Ozempic and Saxenda—treatment indication, dosage, and other factors could play a role, a new study found.

Researchers estimate that expanding access to weight-loss drugs could save over 50,000 lives annually, reducing obesity rates and addressing health inequities. Current drug uptake levels prevent far fewer deaths.